The total pooled analysis showed a statistically substantial percent reduction in body weight of the retatrutide team when contrasted to the sugar pill group after 36 weeks of treatment, with an overall MD of − 14.33 (95% CI: − 18.27 to − 10.39, P retatrutide side effects cancer</a> exposed that customers can shed up to a quarter of their body weight in under a year, making it virtually twice as effective as Ozempic.